Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms

被引：2

作者：

Vormittag-Nocito, Erica ^{[1
]}

Mannan, Rahul ^{[1
,2
]}

Wang, Xiaoming ^{[1
,2
]}

Chinnaiyan, Anya ^{[2
]}

Zhang, Yuping ^{[1
,2
]}

Zelenka-Wang, Sylvia ^{[1
,2
]}

Cao, Xuhong ^{[1
,2
]}

Morgan, Todd M. ^{[2
,3
,6
]}

Hafez, Khaled ^{[6
]}

Vaishampayan, Ulka ^{[5
]}

Abdulfatah, Eman ^{[1
]}

Chinnaiyan, Arul M. ^{[1
,2
,3
,4
,6
]}

Dhanasekaran, Saravana M. ^{[1
,2
]}

Mehra, Rohit ^{[1
,2
,3
,7
]}

机构：

[1] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA

[2] Michigan Ctr Translat Pathol, Ann Arbor, MI USA

[3] Michigan Med, Rogel Canc Ctr, Ann Arbor, MI USA

[4] Howard Hughes Med Inst, Ann Arbor, MI USA

[5] Univ Michigan, Dept Hematol Oncol, Ann Arbor, MI 48109 USA

[6] Univ Michigan, Dept Urol, Sch Med, Ann Arbor, MI 48109 USA

[7] Univ Michigan, Dept Pathol, 2800 Plymouth Rd,Bldg 35, Ann Arbor, MI 48109 USA

来源：

HUMAN PATHOLOGY | 2022年 / 130卷

关键词：

Clear cell renal cell car-cinoma; Tumor heterogeneity; BAP1; SETD2; CAIX; UCHL1; Mutation; Gene expression; Kidney cancer; Immunohistochemistry; BAP1 PROTEIN EXPRESSION; MUTATIONS; SETD2; METHYLATION; PROGNOSIS; PBRM1;

D O I：

10.1016/j.humpath.2022.10.009

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Clear cell renal cell carcinoma (CCRCC) is a common renal malignancy known for its lethality and chromosome 3p aberrancies associated with loss of VHL. It has been shown that addi-tional prognostic molecular markers exist in other transcriptional modifiers such as BAP1 and SETD2. Molecular heterogeneity has been described between primary and metastatic sites as well as genetic diversity in spatial tumor analysis; however, morphologic and proteogenomic heterogeneity informa-tion is lacking. We assessed 77 nephrectomy specimens with a diagnosis of CCRCC for morphologic architectural patterns including nodular growth patterns and variations in WHO/ISUP grade. Evalua-tion of highly heterogeneous areas with immunohistochemical (IHC) staining for BAP1, UCHL1, SETD2, and CAIX was performed and correlated with morphologic and histology data. Ultimately, high variability in the morphologic and histological findings matched the complexity of the IHC find-ings. Alterations in expression of CAIX and UCHL1 correlated with alterations in transcriptional reg-ulators BAP1 and SETD2 within the tumor. High-grade morphology, such as eosinophilia, were areas enriched for alteration of biomarker expression. This highly complex data set of morphologic and biomarker characteristics highlights the heterogeneity of morphology amongst high-grade CCRCC tu-mors. (c) 2022 Elsevier Inc. All rights reserved.

引用

页码：95 / 109

页数：15

共 27 条

[1] Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma [J].

Bihr, Svenja ;

Ohashi, Riuko ;

Moore, Ariane L. ;

Ruschoff, Jan H. ;

Beisel, Christian ;

Hermanns, Thomas ;

Mischo, Axel ;

Corro, Claudia ;

Beyer, Jorg ;

Beerenwinkel, Niko ;

Moch, Holger ;

Schraml, Peter .

NEOPLASIA, 2019, 21 (02) :247-256

[2] Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type [J].

Cai, Qi ;

Christie, Alana ;

Rajaram, Satwik ;

Zhou, Qinbo ;

Araj, Ellen ;

Chintalapati, Suneetha ;

Cadeddu, Jeffrey ;

Margulis, Vitaly ;

Pedrosa, Ivan ;

Rakheja, Dinesh ;

McKay, Renee M. ;

Brugarolas, James ;

Kapur, Payal .

EBIOMEDICINE, 2020, 51

[3] Comprehensivemolecular characterization of clear cell renal cell carcinoma [J].

Creighton, Chad J. ;

Morgan, Margaret ;

Gunaratne, Preethi H. ;

Wheeler, David A. ;

Gibbs, Richard A. ;

Robertson, A. Gordon ;

Chu, Andy ;

Beroukhim, Rameen ;

Cibulskis, Kristian ;

Signoretti, Sabina ;

Vandin, Fabio ;

Wu, Hsin-Ta ;

Raphael, Benjamin J. ;

Verhaak, Roel G. W. ;

Tamboli, Pheroze ;

Torres-Garcia, Wandaliz ;

Akbani, Rehan ;

Weinstein, John N. ;

Reuter, Victor ;

Hsieh, James J. ;

Brannon, A. Rose ;

Hakimi, A. Ari ;

Jacobsen, Anders ;

Ciriello, Giovanni ;

Reva, Boris ;

Ricketts, Christopher J. ;

Linehan, W. Marston ;

Stuart, Joshua M. ;

Rathmell, W. Kimryn ;

Shen, Hui ;

Laird, Peter W. ;

Muzny, Donna ;

Davis, Caleb ;

Morgan, Margaret ;

Xi, Liu ;

Chang, Kyle ;

Kakkar, Nipun ;

Trevino, Lisa R. ;

Benton, Susan ;

Reid, Jeffrey G. ;

Morton, Donna ;

Doddapaneni, Harsha ;

Han, Yi ;

Lewis, Lora ;

Dinh, Huyen ;

Kovar, Christie ;

Zhu, Yiming ;

Santibanez, Jireh ;

Wang, Min ;

Hale, Walker .

NATURE, 2013, 499 (7456) :43-+

[4] Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma [J].

da Costa, Walter Henriques ;

da Cunha, Isabela Werneck ;

Fares, Aline Fusco ;

Bezerra, Stephania M. ;

Shultz, Luciana ;

Clavijo, Diego Abreu ;

da Silva, Deusdedit Vieira ;

Netto, George Jabboure ;

Guimaraes, Gustavo Cardoso ;

Zequi, Stenio de Cassio .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) :243.e1-243.e8

[5] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor [J].

Eckel-Passow, Jeanette E. ;

Serie, Daniel J. ;

Cheville, John C. ;

Ho, Thai H. ;

Kapur, Payal ;

Brugarolas, James ;

Thompson, R. Houston ;

Leibovich, Bradley C. ;

Kwon, Eugene D. ;

Joseph, Richard W. ;

Parker, Alexander S. .

BMC UROLOGY, 2017, 17 :1-7

[6]

Gallan AJ, 2021, AM J CLIN PATHOL, V155, P718, DOI [10.1093/AJCP/AQAA176, 10.1093/ajcp/aqaa176]

[7] Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].

Gerlinger, Marco ;

Rowan, Andrew J. ;

Horswell, Stuart ;

Larkin, James ;

Endesfelder, David ;

Gronroos, Eva ;

Martinez, Pierre ;

Matthews, Nicholas ;

Stewart, Aengus ;

Tarpey, Patrick ;

Varela, Ignacio ;

Phillimore, Benjamin ;

Begum, Sharmin ;

McDonald, Neil Q. ;

Butler, Adam ;

Jones, David ;

Raine, Keiran ;

Latimer, Calli ;

Santos, Claudio R. ;

Nohadani, Mahrokh ;

Eklund, Aron C. ;

Spencer-Dene, Bradley ;

Clark, Graham ;

Pickering, Lisa ;

Stamp, Gordon ;

Gore, Martin ;

Szallasi, Zoltan ;

Downward, Julian ;

Futreal, P. Andrew ;

Swanton, Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892

[8] Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network [J].

Hakimi, A. Ari ;

Ostrovnaya, Irina ;

Reva, Boris ;

Schultz, Nikolaus ;

Chen, Ying-Bei ;

Gonen, Mithat ;

Liu, Han ;

Takeda, Shugaku ;

Voss, Martin H. ;

Tickoo, Satish K. ;

Reuter, Victor E. ;

Russo, Paul ;

Cheng, Emily H. ;

Sander, Chris ;

Motzer, Robert J. ;

Hsieh, James J. .

CLINICAL CANCER RESEARCH, 2013, 19 (12) :3259-3267

[9] Loss of BAP1 Protein Expression Is an Independent Marker of Poor Prognosis in Patients With Low-Risk Clear Cell Renal Cell Carcinoma [J].

Joseph, Richard W. ;

Kapur, Payal ;

Serie, Daniel J. ;

Eckel-Passow, Jeanette E. ;

Parasramka, Mansi ;

Ho, Thai ;

Cheville, John C. ;

Frenkel, Eugene ;

Rakheja, Dinesh ;

Brugarolas, James ;

Parker, Alexander .

CANCER, 2014, 120 (07) :1059-1067

[10] Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation [J].

Kapur, Payal ;

Pena-Llopis, Samuel ;

Christie, Alana ;

Zhrebker, Leah ;

Pavia-Jimenez, Andrea ;

Rathmell, W. Kimryn ;

Xie, Xian-Jin ;

Brugarolas, James .

LANCET ONCOLOGY, 2013, 14 (02) :159-167

← 1 2 3 →